Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 6 |
GO:0042995 | cell projection | 2 | 6 |
GO:0043226 | organelle | 2 | 6 |
GO:0043227 | membrane-bounded organelle | 3 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 6 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AI86
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.424 |
CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.303 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.462 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 146 | 148 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.414 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.440 |
DOC_MAPK_gen_1 | 146 | 153 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 146 | 153 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 250 | 258 | PF00069 | 0.459 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.640 |
LIG_14-3-3_CanoR_1 | 100 | 104 | PF00244 | 0.289 |
LIG_14-3-3_CanoR_1 | 40 | 46 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 51 | 57 | PF00244 | 0.338 |
LIG_14-3-3_CanoR_1 | 9 | 18 | PF00244 | 0.516 |
LIG_Actin_WH2_2 | 103 | 118 | PF00022 | 0.287 |
LIG_Actin_WH2_2 | 38 | 53 | PF00022 | 0.437 |
LIG_APCC_ABBA_1 | 181 | 186 | PF00400 | 0.419 |
LIG_Clathr_ClatBox_1 | 110 | 114 | PF01394 | 0.407 |
LIG_eIF4E_1 | 36 | 42 | PF01652 | 0.435 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.344 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.319 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.245 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.561 |
LIG_FHA_1 | 249 | 255 | PF00498 | 0.411 |
LIG_FHA_2 | 10 | 16 | PF00498 | 0.632 |
LIG_LIR_Gen_1 | 179 | 187 | PF02991 | 0.282 |
LIG_LIR_Gen_1 | 210 | 219 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 179 | 183 | PF02991 | 0.261 |
LIG_LIR_Nem_3 | 210 | 215 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 221 | 227 | PF02991 | 0.360 |
LIG_LYPXL_yS_3 | 224 | 227 | PF13949 | 0.411 |
LIG_PDZ_Class_2 | 253 | 258 | PF00595 | 0.473 |
LIG_Pex14_2 | 107 | 111 | PF04695 | 0.399 |
LIG_SH2_GRB2like | 92 | 95 | PF00017 | 0.427 |
LIG_SH2_SRC | 185 | 188 | PF00017 | 0.455 |
LIG_SH2_STAT3 | 211 | 214 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.214 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.481 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.577 |
LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.427 |
LIG_SH3_1 | 146 | 152 | PF00018 | 0.462 |
LIG_SH3_2 | 225 | 230 | PF14604 | 0.446 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.331 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.581 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.448 |
LIG_SUMO_SIM_anti_2 | 156 | 161 | PF11976 | 0.357 |
LIG_SUMO_SIM_par_1 | 158 | 164 | PF11976 | 0.433 |
LIG_SUMO_SIM_par_1 | 19 | 24 | PF11976 | 0.485 |
LIG_WRC_WIRS_1 | 177 | 182 | PF05994 | 0.261 |
MOD_CDK_SPK_2 | 245 | 250 | PF00069 | 0.409 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.506 |
MOD_CK1_1 | 248 | 254 | PF00069 | 0.469 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.321 |
MOD_CK2_1 | 16 | 22 | PF00069 | 0.426 |
MOD_CK2_1 | 9 | 15 | PF00069 | 0.632 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.474 |
MOD_GSK3_1 | 245 | 252 | PF00069 | 0.581 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.603 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.443 |
MOD_LATS_1 | 7 | 13 | PF00433 | 0.518 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.328 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.283 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.423 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.590 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.528 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.311 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.477 |
MOD_NEK2_2 | 52 | 57 | PF00069 | 0.424 |
MOD_PIKK_1 | 9 | 15 | PF00454 | 0.516 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.448 |
MOD_PKA_2 | 8 | 14 | PF00069 | 0.548 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.285 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.362 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.377 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.446 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.458 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.640 |
TRG_ENDOCYTIC_2 | 224 | 227 | PF00928 | 0.437 |
TRG_ER_diArg_1 | 228 | 230 | PF00400 | 0.462 |
TRG_NES_CRM1_1 | 49 | 59 | PF08389 | 0.412 |
TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.309 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IKD6 | Leishmania donovani | 81% | 83% |
A4HYM2 | Leishmania infantum | 81% | 83% |
E9AUH1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 83% |
Q4QD13 | Leishmania major | 80% | 100% |